07
February
2020
3 Key Takeaways from the Digital Pharma Advances Conference
Key learnings from our time at Digital Pharma Advances conference and news about our upcoming HCP marketing preferences report.
Read More
Key learnings from our time at Digital Pharma Advances conference and news about our upcoming HCP marketing preferences report.
Read MoreWhat if there were 100 people on earth living with cancer? What would that look like?
Read MoreOur client’s market-leading product had reached a sales plateau after notable growth since launch.
Read MoreAdopting a multi-disciplinary approach that goes beyond speaking to patients, to understanding what drives decision making and purchase behaviour for treatments.
Read MoreMCDA is a highly flexible and powerful analytical approach that unpicks multi-level decision-making.
Read MoreRead results from Bryter's JAK inhibitor study - a breakthrough treatment for blood and bone marrow cancers.
Read More8 in 10 UK oncologists agree that the NHS could fall behind the health systems of other developed countries
Read MoreSo, we need stats to test our pipeline drug - but which technique do we use?
Read More
